MX2018007468A - Composiciones de colageno 7 y metodos para usar las mismas. - Google Patents
Composiciones de colageno 7 y metodos para usar las mismas.Info
- Publication number
- MX2018007468A MX2018007468A MX2018007468A MX2018007468A MX2018007468A MX 2018007468 A MX2018007468 A MX 2018007468A MX 2018007468 A MX2018007468 A MX 2018007468A MX 2018007468 A MX2018007468 A MX 2018007468A MX 2018007468 A MX2018007468 A MX 2018007468A
- Authority
- MX
- Mexico
- Prior art keywords
- collagen
- compositions
- methods
- same
- present disclosure
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title abstract 2
- 108010035532 Collagen Proteins 0.000 title abstract 2
- 229920001436 collagen Polymers 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562387241P | 2015-12-23 | 2015-12-23 | |
US201662278816P | 2016-01-14 | 2016-01-14 | |
US201662293209P | 2016-02-09 | 2016-02-09 | |
PCT/US2016/067995 WO2017112757A1 (en) | 2015-12-23 | 2016-12-21 | Collagen 7 compositions and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018007468A true MX2018007468A (es) | 2018-11-14 |
Family
ID=59091196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018007468A MX2018007468A (es) | 2015-12-23 | 2016-12-21 | Composiciones de colageno 7 y metodos para usar las mismas. |
Country Status (8)
Country | Link |
---|---|
US (3) | US10695395B2 (de) |
EP (1) | EP3394095B1 (de) |
JP (3) | JP6943858B2 (de) |
CN (2) | CN114225013A (de) |
CA (1) | CA3006998A1 (de) |
IL (2) | IL259583B (de) |
MX (1) | MX2018007468A (de) |
WO (1) | WO2017112757A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6943858B2 (ja) * | 2015-12-23 | 2021-10-06 | フェニックス ティシュー リペア インコーポレイテッドPhoenix Tissue Repair,Inc. | コラーゲン7組成物及びそれを用いる方法 |
CN114401769A (zh) * | 2019-03-27 | 2022-04-26 | 菲尼克斯组织修复公司 | 生产胶原蛋白7组合物的系统和方法 |
CA3234797A1 (en) | 2021-10-12 | 2023-04-20 | Hal Landy | Collagen 7 protein replacement therapy |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2757874B1 (fr) * | 1996-12-17 | 2003-04-25 | Biocem | Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations |
PL215168B1 (pl) * | 2002-02-27 | 2013-10-31 | Immunex Corp | Formulacja polipeptydowa |
GB0216001D0 (en) | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
US20080287349A1 (en) * | 2003-05-09 | 2008-11-20 | Jeffrey Peterson | Fibroblast growth factor 20 and methods of use thereof |
EP3378470A1 (de) * | 2003-12-19 | 2018-09-26 | Novo Nordisk Health Care AG | Stabilisierte zusammensetzungen aus faktor-vii-polypeptiden |
JP4832107B2 (ja) * | 2006-02-23 | 2011-12-07 | ソニーケミカル&インフォメーションデバイス株式会社 | 実装方法 |
CN101627117B (zh) | 2006-08-01 | 2013-10-30 | 奇尼塔二有限责任公司 | 医药制造方法 |
WO2011017070A1 (en) * | 2009-07-28 | 2011-02-10 | Merck Sharp & Dohme Corp. | Methods for producing high concentration lyophilized pharmaceutical formulations |
US8475824B2 (en) * | 2010-01-26 | 2013-07-02 | Warsaw Orthopedic, Inc. | Resorbable matrix having elongated particles |
WO2011113024A1 (en) * | 2010-03-11 | 2011-09-15 | University Of Southern California | Compositions and methods for healing of skin wounds |
AU2011249858B2 (en) * | 2010-05-06 | 2016-07-21 | University Of Southern California Usc Stevens | Methods and agents for enhancing wound healing |
US9453067B2 (en) * | 2011-04-20 | 2016-09-27 | Sandoz Ag | Stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc |
CA2854160A1 (en) * | 2011-11-02 | 2013-05-10 | Halscion, Inc. | Methods and compositions for wound treatment |
US20180104186A1 (en) * | 2013-03-13 | 2018-04-19 | University Of Miami | Methods and compositions for the treatment of epidermolysis bullosa |
CN104740612A (zh) * | 2013-12-31 | 2015-07-01 | 上海中信国健药业股份有限公司 | 一种受体抗体融合蛋白的液体制剂 |
JP2017513833A (ja) * | 2014-04-08 | 2017-06-01 | ユニヴァーシティー オブ サザン カリフォルニア | Vii型コラーゲンフィブロネクチンiii型様リピートを有するポリペプチド組成物ならびに創傷の閉鎖および治癒のための治療方法 |
JP6943858B2 (ja) * | 2015-12-23 | 2021-10-06 | フェニックス ティシュー リペア インコーポレイテッドPhoenix Tissue Repair,Inc. | コラーゲン7組成物及びそれを用いる方法 |
JP6985282B2 (ja) * | 2016-03-16 | 2021-12-22 | フェニックス ティシュー リペア インコーポレイテッドPhoenix Tissue Repair, Inc. | 7型コラーゲンの精製方法 |
-
2016
- 2016-12-21 JP JP2018533834A patent/JP6943858B2/ja active Active
- 2016-12-21 CN CN202111171969.1A patent/CN114225013A/zh active Pending
- 2016-12-21 MX MX2018007468A patent/MX2018007468A/es unknown
- 2016-12-21 CN CN201680075057.5A patent/CN108463470B/zh active Active
- 2016-12-21 EP EP16880019.1A patent/EP3394095B1/de active Active
- 2016-12-21 US US16/065,512 patent/US10695395B2/en active Active
- 2016-12-21 WO PCT/US2016/067995 patent/WO2017112757A1/en active Application Filing
- 2016-12-21 CA CA3006998A patent/CA3006998A1/en active Pending
-
2018
- 2018-05-24 IL IL259583A patent/IL259583B/en unknown
-
2020
- 2020-05-15 US US16/875,223 patent/US20200316158A1/en not_active Abandoned
-
2021
- 2021-09-09 JP JP2021146575A patent/JP2021185201A/ja active Pending
-
2022
- 2022-01-27 IL IL290166A patent/IL290166A/en unknown
-
2023
- 2023-02-15 US US18/169,368 patent/US20230414698A1/en active Pending
- 2023-10-02 JP JP2023171324A patent/JP2023166014A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10695395B2 (en) | 2020-06-30 |
CN108463470A (zh) | 2018-08-28 |
JP2023166014A (ja) | 2023-11-17 |
EP3394095B1 (de) | 2023-09-27 |
EP3394095A1 (de) | 2018-10-31 |
EP3394095A4 (de) | 2019-08-14 |
JP6943858B2 (ja) | 2021-10-06 |
JP2021185201A (ja) | 2021-12-09 |
CA3006998A1 (en) | 2017-06-29 |
WO2017112757A1 (en) | 2017-06-29 |
US20190000912A1 (en) | 2019-01-03 |
US20200316158A1 (en) | 2020-10-08 |
IL290166A (en) | 2022-03-01 |
IL259583B (en) | 2022-03-01 |
JP2019504043A (ja) | 2019-02-14 |
CN114225013A (zh) | 2022-03-25 |
CN108463470B (zh) | 2021-10-22 |
US20230414698A1 (en) | 2023-12-28 |
IL259583A (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2016011110A (es) | Composiciones anti-espuma. | |
PH12016501441A1 (en) | Chimeric alkaline phosphate-like proteins | |
MX2017001279A (es) | Usos y composiciones de la flagelina. | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
MX2018000715A (es) | Metodos para tratar cancer usando apilimod. | |
WO2015120138A3 (en) | AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF | |
MY193650A (en) | Extracellular matrix compositions | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
MX2019010984A (es) | Composiciones de sintecina y metodos de uso. | |
MX2020003762A (es) | Composiciones cosmeticas y metodo para tratar la piel. | |
MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
MX2018012797A (es) | Inhibidores de erbb y usos de los mismos. | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
PH12016501838A1 (en) | Compounds and their methods of use | |
MY191337A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
PH12017501022A1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
MX2018016037A (es) | Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa. | |
MX2018007468A (es) | Composiciones de colageno 7 y metodos para usar las mismas. | |
PH12016501658A1 (en) | Sialylated glycoprotein compositions and uses thereof | |
GEP201706795B (en) | Hexahydrofuropyrroles as pde1 inhibitors | |
MY182818A (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
MX2018000708A (es) | Composiciones y metodos para desgomar aceite. |